The Readout Loud cover image

387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

The Readout Loud

00:00

Novo Nordisk vs. Eli Lilly financial split

Elaine explains divergent sales forecasts from Novo Nordisk and Eli Lilly and differing investor reactions.

Play episode from 03:27
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app